Stocks and Investing Stocks and Investing
Wed, September 16, 2020
Tue, September 15, 2020
Mon, September 14, 2020
Fri, September 11, 2020
Thu, September 10, 2020
Wed, September 9, 2020
Tue, September 8, 2020

Joel Beatty Initiated (ALNY) at Strong Buy and Held Target at $170 on, Sep 8th, 2020


Published on 2024-10-27 13:04:17 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Citigroup, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $170 on, Sep 8th, 2020.

Joel has made no other calls on ALNY in the last 4 months.



There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 4 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold and Decreased Target to $156 on, Tuesday, August 11th, 2020
  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $90 on, Friday, August 7th, 2020
  • Esther Rajavelu of "UBS" Maintained at Hold with Increased Target to $122 on, Thursday, May 28th, 2020
  • Luca Issi of "RBC Capital" Initiated at Hold and Held Target at $150 on, Wednesday, May 13th, 2020


This is the rating of the analyst that currently disagrees with Joel


  • David Lebovitz of "Morgan Stanley" Maintained at Buy with Decreased Target to $197 on, Friday, August 7th, 2020